MIST Milestone Pharmaceuticals Inc.

0.7572USD-0.92%Mkt Cap: 94.27M $P/E: —

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a pr…

Key Statistics

Company
Market Cap94.27M USD
Enterprise Value78.91M USD
Revenue (TTM)2.34M USD
Gross Profit2.30M USD
Net Income (TTM)-63.06M USD
Revenue/Share0.02 USD
Last Price0.7572 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees38
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.99
PEG—
EV/EBITDA-1.01
EV/Revenue33.68
P/S40.61
P/B5.92
EPS (TTM)-0.68
EPS (Forward)-0.77
52W Range
0.72571% of range3.060
52W High3.060 USD
52W Low0.7257 USD
Profitability
Gross Margin98.04%
Oper. Margin-4584.97%
EBITDA Margin0.00%
Profit Margin-4078.78%
ROE-150.97%
ROA-55.53%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-49.04M USD
CapEx (TTM)302.00K USD
FCF Margin-1779.23%
FCF Yield-44.22%
Net Debt-28.78M USD
Net Debt/EBITDA0.37
Balance Sheet
Debt/Equity1.40
Current Ratio8.13
Quick Ratio7.87
Book Value/Sh0.13 USD
Cash/Share1.21 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.857 USD
Upside (mean)+673.5%
Target Range2.000 USD – 8.000 USD
2.000+673.5% to mean8.000
# Analysts7
Ownership
Shares Out.124.50M
Float106.47M
Insiders0.70%
Institutions50.57%
Short Interest
Short Ratio11.2d
Short % Float14.85%
Short % Out.14.75%
Shares Short18.36M
Short (prev mo.)16.64M
Technical
SMA 501.042 (-27.3%)
SMA 2001.499 (-49.5%)
Beta1.01
S&P 52W Chg16.45%
Avg Vol (30d)1.38M
Avg Vol (10d)1.20M
Technical Indicators
RSI (14)28.5
MACD-0.0877
MACD Signal-0.0839
MACD Hist.-0.0038
BB Upper1.101 USD
BB Middle0.8855 USD
BB Lower0.6700 USD
BB Width48.67%
ATR (14)0.0615 USD
Vol Ratio (20d)0.64x